Mike Ward

London

Global Head of Thought Leadership at Clarivate

Commentating on issues consequential to pharma, biotech, healthcare & medtech stakeholders

Featured in: Favicon

express.co.uk Favicon

dailystar.co.uk Favicon

informa.com (+3) Favicon

sentinelsource.com Favicon

paymentsjournal.com Favicon

pharmatimes.com Favicon

bioworld.com Favicon

datamonitor.com Favicon

homebusinessmag.com Favicon

pharmamedtechbi.com + 8 more

Articles

Seventure Reaffirms Microbiome Confidence With New €200m Fund

Jan 9, 2025 | insights.citeline.com | Mike Ward

Seventure Reaffirms Microbiome Confidence With New €200m Fund06 Mar 2019 • By Mike WardWith its first microbiome fund completing its investment period, French venture capitalist Seventure Partners has raised more than €100m of a €200m target for its second microbiome-focused fund. Exponential increase in microbiome potential
Lundbeck Looks For Assets Across Value Chain To Ride Storm

Dec 10, 2024 | insights.citeline.com | Mike Ward

Lundbeck Looks For Assets Across Value Chain To Ride Storm08 Feb 2019 • By Mike WardWhile the Danish pharma unveiled its best ever financial results, recently installed ceo Deborah Dunsire confirms to Scrip that the company needs to bolster its pipeline and portfolio with assets in all phases of the value chain. Lundbeck Maintains Focus On Brain Diseases • Source: Shutterstock
Increasing your likelihood of success in dealmaking discussions

Oct 17, 2024 | clarivate.com | Mike Ward |Sonia Lopez

In-licensing and acquisitions are fast tracks for pharmaceutical companies to access groundbreaking technologies and assets that will drive the next generation of transformative patient treatments. Dealmaking is not a trivial process. Audience members during the recent Clarivate webinar Emerging Deal Trends in Biotech and Pharma identified three of the biggest challenges they face when securing deals.
Biotech financing’s rebound: How high will it go?

Sep 17, 2024 | clarivate.com | Mike Ward |Varun Saxena

The biotech industry has experienced a rollercoaster of financing and dealmaking trends over the past few years. From the record-breaking heights of the COVID-19 era to the recent slowdown in 2023, signs of resilience and recovery are beginning to emerge. In the first half of 2024, the biotech industry is witnessing early signs of a rebound in financing and dealmaking activities. However, it may not reach the peak levels seen during the height of the pandemic.
Speak No Evil (2024)

Sep 13, 2024 | shouldiseeit.net | Mike Ward |Christian Tafdrup |Mads Tafdrup

R Running Time: 110 mins SHOULD I SEE IT? Protect James McAvoy at all costs. As a diabolical, unhinged villain - there may be no one better at this right now. Entertaining and quite witty for a long duration of the film’s run time, with an uneasy tension building the entire time, Speak No Evil is one of 2024’s biggest surprises. The film alters the 2022 Danish original film’s conclusion. For mainstream American audiences, this will not be a complaint.
Should I See It-Twisters (2024)

Jul 19, 2024 | shouldiseeit.net | Mike Ward |Michael Crichton |Anne-Marie Martin

PG-13 Running Time: 117 mins SHOULD I SEE IT? It’s been a good long while since a massive disaster epic hit summer movie season. The line for Twisters starts just over there. Glen Powell’s charm and charisma complements co-star Daisy Edgar-Jones’ more serious performance and Twisters strives to find a balance of humor, romance, action and thrilling effects-laden intensity. Never boring, though the film peaks with a fantastic opening 15-20 minute sequence.
Challengers (2024)

Apr 27, 2024 | shouldiseeit.net | Mike Ward

R Running Time: 131 mins SHOULD I SEE IT? One of 2024’s best films. Challengers is a wildly entertaining experience that keeps you guessing until the final scene. Zendaya, Mike Faist and Josh O’Connor all level up with performances that could easily be remembered come awards season in the fall.
The People's Joker (2024)

Apr 26, 2024 | shouldiseeit.net | Mike Ward

NR Running Time: 92 mins SHOULD I SEE IT? An underground film with a massive heart of gold, The People’s Joker is brave, bold, a little dangerous and one of the more fascinating movies in recent memory. Vera Drew, an Emmy-nominated editor, wears nearly every hat in bringing this deeply personal “anti-comedy” to the big screen.
Monkey Man (2024)

Apr 4, 2024 | shouldiseeit.net | Mike Ward

R Running Time: 113 mins SHOULD I SEE IT? While not quite John Wick, the fight sequences alone make this a must see film.*(*for audiences into this kind of thing.) Patel seems rather fearless as a filmmaker and Monkey Man finds him doing everything - acting, directing, co-writing, producing. This is very much his passion project. Amid the noise and chaos of how the film is put together, there are some wonderful moments sprinkled in which could resonate with audiences.
Late Night With The Devil (2024)

Mar 30, 2024 | shouldiseeit.net | Mike Ward

R Running Time: 93 mins SHOULD I SEE IT? Not every horror film needs to have a slasher or jump scare component and Late Night with the Devil reminds us that visual terror is often less scary than the anticipation and fear of what could be coming. David Dastmalchian is fantastic, with one of the first great performances of 2024. Perfectly cast in the role of the smarmy talk show host at the center of the happenings.